SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001640334-19-001039
Filing Date
2019-06-04
Accepted
2019-06-04 16:39:12
Documents
1
Period of Report
2019-06-03

Document Format Files

Seq Description Document Type Size
1 FORM 4 form4.html 4  
1 FORM 4 form4.xml 4 3152
  Complete submission text file 0001640334-19-001039.txt   4511
Mailing Address 1224 PROSPECT STREET SUITE 150 LA JOLLA CA 92037
Business Address 1224 PROSPECT STREET SUITE 150 LA JOLLA CA 92037 8589643720
Inmune Bio, Inc. (Issuer) CIK: 0001711754 (see all company filings)

IRS No.: 475205835 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 325 N. LARCHMONT BLVD, SUITE 375 LOS ANGELES CA 90004
Business Address
Juda Scott (Reporting) CIK: 0001767084 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38793 | Film No.: 19877113